Leading Pharmaceuticals Come Together To Develop Potential Vaccine For Covid-19

Covid-19 vaccine trials to begin soon by GSK and J&J. Mass production and distribution of billions of potential vaccine dose to begin soon by GSK.
Sshradha Sinngh
By: Sshradha Sinngh Updated: Jun 11, 2020 13:30 IST
Leading Pharmaceuticals Come Together To Develop Potential Vaccine For Covid-19
GSK and J&J : On Covid-19 Potential Vaccine

Britain based leading vaccine company GlaxoSmithKline (GSK) is planning on rolling out a billion of its potential Covid-19 vaccines.This vaccine is being made in collaboration with Sanofi, a French multinational pharmaceutical company, and will be made available only by the second half of 2021.

Developing a vaccine for Covid-19 within 15-18 months will be quite an achievement. This speed up on the vaccine development is all thanks to the previous research on SARS, MERS and the prior coronaviruses.

This vaccine production is being produced at nine sites globally, and the manufacturers aim to make it available at the earliest . It is very early to talk about the pricing of the vaccine, but they are committed at making it available at affordable prices.

Similarly Johnsons & Johnsons (J&J) as on June 10 sped up the first in-human clinical trial of SARS-CoV-2 vaccine to be able to produce it by July end. This was earlier scheduled for September.

Also, J&J is expanding their global partnerships to speed up the vaccine's production technology and manufacturing capabilities.

This random vaccine evaluation will be done on 1,045 healthy adults aged 18 to 55, and also on people older than 65 years.

For the latest deals, offers and news, follow HotDeals360 on Facebook, Twitter, Instagram, Google News and subscribe to our YouTube channel.
The HotDeals360 team writes about stuff we think you'll like. HotDeals360 has affiliate partnerships, so we get a share of the revenue from your purchase.